Inventor · disambiguated record
Michael Carleton
Also filed as: CARLETON MICHAEL · CARLETON MICHAEL O
7 granted patents·10 pending applications·29 citations·filing 2008–2022
83Inventor score
Files withLUMEN BIOSCIENCE INC4MATRIX GENETICS LLC3ABRAXIS BIOSCIENCE LLC2BRISTOL MYERS SQUIBB CO2FIVE PRIME THERAPEUTICS INC2
Top patents by PatentIndex Score
17 records- 0195US11279912B2Cyanobacteria having improved photosynthetic activityLUMEN BIOSCIENCE INC·Filed 2020·Granted Mar 22, 2022·4 cites·4 claims
- 0295US10760045B2Cyanobacteria having improved photosynthetic activityLUMEN BIOSCIENCE INC·Filed 2020·Granted Sep 1, 2020·5 cites·18 claims
- 0393US10563168B2Cyanobacteria having improved photosynthetic activityLUMEN BIOSCIENCE INC·Filed 2018·Granted Feb 18, 2020·6 cites·8 claims
- 0490US9914907B2Cyanobacteria having improved photosynthetic activityLUMEN BIOSCIENCE INC·Filed 2014·Granted Mar 13, 2018·8 cites·23 claims
- 0579US9523096B2Modified photosynthetic microorganisms for producing lipidsROBERTS JAMES·Filed 2011·Granted Dec 20, 2016·4 cites·20 claims
- 0676US11572405B2Combination therapy with anti-IL-8 antibodies and anti-PD-1 antibodies for treating cancerBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Feb 7, 2023·2 cites·28 claims
- 0765US2023192870A1Combination Anti-CSF1R and Anti-PD-1 Antibody Combination Therapy for Pancreatic CancerFIVE PRIME THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0863US2023279096A1Combination therapy with anti-il-8 antibodies and anti-pd-1 antibodies for treating cancerBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 0963US2020246275A1Combination therapy comprising nanoparticles of a taxane and albumin with abt-263 in methods for treating cancerABRAXIS BIOSCIENCE LLC·Filed 2019·Application pending·0 cites
- 1059US11421034B2Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic cancerFIVE PRIME THERAPEUTICS INC·Filed 2018·Granted Aug 23, 2022·0 cites·15 claims
- 1153US2011166200A1Methods of using mir210 as a biomarker for hypoxia and as a therapeutic agent for treating cancerZHANG ZHAN·Filed 2009·Application pending·0 cites
- 1249US2009136957A1Methods and compositions for regulating cell cycle progression via the miR-106B familyIVANOVSKA IRENA·Filed 2008·Application pending·0 cites
- 1349US2023416802A1Specific substrates and products of hsd17b13 as markers of liver disease and biomarkers for liver disease treatmentINIPHARM INC·Filed 2021·Application pending·0 cites
- 1449US2017202782A1Combination therapy comprising nanoparticles of a taxane and albumin with abt-263 in methods for treating cancerABRAXIS BIOSCIENCE LLC·Filed 2015·Application pending·0 cites
- 1539US2015024442A1Modified diacylglycerol acyltransferase proteins and methods of use thereofMATRIX GENETICS LLC·Filed 2013·Application pending·0 cites
- 1636US2015329868A1Modified photosynthetic microorganisms for continuous production of carbon-containing compoundsMATRIX GENETICS LLC·Filed 2013·Application pending·0 cites
- 1733US2018051057A1Cyanobacteria having improved photosynthetic activityMATRIX GENETICS LLC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Carleton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →